Ye X - Search Results

1

Melanoma-inhibiting activity assay predicts survival in patients receiving a therapeutic cancer vaccine after complete resection of American Joint Committee on Cancer Stage III Melanoma.

Faries MB, Gupta RK, Ye X, Hsueh EC, Morton DL. Faries MB, et al. Among authors: ye x. Ann Surg Oncol. 2004 Jan;11(1):85-93. doi: 10.1007/BF02524351. Ann Surg Oncol. 2004. PMID: 14699039

2

Peripheral blood CD4+ T-cell response before postoperative active immunotherapy correlates with clinical outcome in metastatic melanoma.

Hsueh EC, Famatiga E, Shu S, Ye X, Morton DL. Hsueh EC, et al. Among authors: ye x. Ann Surg Oncol. 2004 Oct;11(10):892-9. doi: 10.1245/ASO.2004.02.018. Epub 2004 Sep 20. Ann Surg Oncol. 2004. PMID: 15383418

3

A Comparison of 3 tumor markers (MIA, TA90IC, S100B) in stage III melanoma patients.

Faries MB, Gupta RK, Ye X, Lee C, Yee R, Leopoldo Z, Essner R, Foshag LJ, Elashoff D, Morton DL. Faries MB, et al. Among authors: ye x. Cancer Invest. 2007 Aug;25(5):285-93. doi: 10.1080/07357900701208634. Cancer Invest. 2007. PMID: 17661202

4

Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma.

Scheri RP, Essner R, Turner RR, Ye X, Morton DL. Scheri RP, et al. Among authors: ye x. Ann Surg Oncol. 2007 Oct;14(10):2861-6. doi: 10.1245/s10434-007-9472-y. Epub 2007 Jul 18. Ann Surg Oncol. 2007. PMID: 17882497

5

Monocyte-derived IL-10 expression predicts prognosis of stage IV melanoma patients.

Torisu-Itakura H, Lee JH, Huynh Y, Ye X, Essner R, Morton DL. Torisu-Itakura H, et al. Among authors: ye x. J Immunother. 2007 Nov-Dec;30(8):831-8. doi: 10.1097/CJI.0b013e318158795b. J Immunother. 2007. PMID: 18049335

6

Importance of sentinel lymph node biopsy in patients with thin melanoma.

Wright BE, Scheri RP, Ye X, Faries MB, Turner RR, Essner R, Morton DL. Wright BE, et al. Among authors: ye x. Arch Surg. 2008 Sep;143(9):892-9; discussion 899-900. doi: 10.1001/archsurg.143.9.892. Arch Surg. 2008. PMID: 18794428 Free PMC article.

7

Solitary dermal melanoma: beginning or end of the metastatic process?

Lee CC, Faries MB, Ye X, Morton DL. Lee CC, et al. Among authors: ye x. Ann Surg Oncol. 2009 Mar;16(3):578-84. doi: 10.1245/s10434-008-0272-9. Epub 2009 Jan 6. Ann Surg Oncol. 2009. PMID: 19130137 Free PMC article.

8

Effect of granulocyte/macrophage colony-stimulating factor on vaccination with an allogeneic whole-cell melanoma vaccine.

Faries MB, Hsueh EC, Ye X, Hoban M, Morton DL. Faries MB, et al. Among authors: ye x. Clin Cancer Res. 2009 Nov 15;15(22):7029-35. doi: 10.1158/1078-0432.CCR-09-1540. Epub 2009 Nov 10. Clin Cancer Res. 2009. PMID: 19903777 Free PMC article. Clinical Trial.

9

Late recurrence in melanoma: clinical implications of lost dormancy.

Faries MB, Steen S, Ye X, Sim M, Morton DL. Faries MB, et al. Among authors: ye x. J Am Coll Surg. 2013 Jul;217(1):27-34; discussion 34-6. doi: 10.1016/j.jamcollsurg.2013.03.007. Epub 2013 May 3. J Am Coll Surg. 2013. PMID: 23643694 Free PMC article.

10

Prolonged survival after complete resection of disseminated melanoma and active immunotherapy with a therapeutic cancer vaccine.

Hsueh EC, Essner R, Foshag LJ, Ollila DW, Gammon G, O'Day SJ, Boasberg PD, Stern SL, Ye X, Morton DL. Hsueh EC, et al. Among authors: ye x. J Clin Oncol. 2002 Dec 1;20(23):4549-54. doi: 10.1200/JCO.2002.01.151. J Clin Oncol. 2002. PMID: 12454111 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,411 results

Search Page

Filters